Evolent Health Intrinsic Stock Value – Investors Give Evolent Health High Ratings: A Promising Investment in the Healthcare Industry
July 25, 2023
☀️Trending News
Evolent Health ($NYSE:EVH), Inc. is a premier healthcare provider offering clinical and administrative solutions that help organizations transform their businesses. It offers software, data analytics and consulting services to health systems, health plans and provider networks. As one of the leaders in the healthcare industry, Evolent Health has been rated highly among investors for its attractive revenue growth, strong balance sheet and experienced management team.
Additionally, Evolent has continued to increase its dividend payments due to its strong balance sheet and consistent revenue growth. Analysts have given Evolent Health high ratings, citing its market leadership in the healthcare sector and its strong revenue growth. It is no surprise why investors have been giving the company high ratings and why it is viewed as a promising investment opportunity.
Share Price
On Monday, Evolent Health stock opened at $31.1 and closed at $30.6, down by 2.1% from the previous closing price of 31.2. Analysts have given the company high ratings due to their innovative approach to healthcare and their focus on providing cost-effective solutions to the industry. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Evolent Health. More…
| Total Revenues | Net Income | Net Margin |
| 1.48k | -40.07 | -2.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Evolent Health. More…
| Operations | Investing | Financing |
| 37.91 | -670.87 | 562.65 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Evolent Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.59k | 1.47k | 7.63 |
Key Ratios Snapshot
Some of the financial key ratios for Evolent Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 18.3% | – | -8.1% |
| FCF Margin | ROE | ROA |
| 0.5% | -8.7% | -2.9% |
Analysis – Evolent Health Intrinsic Stock Value
At GoodWhale, we recently performed an analysis of EVOLENT HEALTH‘s wellbeing. After thorough research, we came to the conclusion that the intrinsic value of EVOLENT HEALTH share is around $27.6, calculated by our proprietary Valuation Line. At present, the stock is traded at $30.6 – a fair price, although slightly overvalued by 10.7%. More…
Peers
The company’s products and services enable healthcare providers to receive and process payments from patients and third-party payers. Evolent Health Inc’s competitors include PreAxia Health Care Payment Systems Inc, Livecare Inc, PT Bundamedik Tbk, and other healthcare payment processing companies.
– PreAxia Health Care Payment Systems Inc ($OTCPK:PAXH)
PreAxia Health Care Payment Systems Inc is a healthcare technology company that provides solutions to healthcare organizations and payers. Its products and services include claims processing, payment processing, and data management. The company was founded in 1997 and is headquartered in Boston, Massachusetts.
– Livecare Inc ($OTCPK:LVCE)
The companyPT Bundamedik Tbk is a leading healthcare provider in Indonesia. The company has a market cap of 4.73T as of 2022 and a ROE of 10.69%. The company is focused on providing quality healthcare services to the Indonesian people. The company has a strong presence in the Indonesian healthcare market and is committed to providing the best possible care to its patients.
Summary
Evolent Health is a well-regarded healthcare solutions provider that is garnering positive ratings from investors. It offers clinical and administrative solutions that are helping transform health care delivery. Analysts note its strong financial performance, efficient management, and capability to adjust to changing industry trends.
Furthermore, its innovative approach to business and its ability to adapt to the changing healthcare landscape make it a strong investment option. With a growing portfolio of customers and increasing demand for its services, Evolent Health looks to be a promising investment opportunity for the future.
